Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 14,523 | 11,647 | 9,693 | 63,745 | 17,399 |
| Gross Profit | 14,523 | 11,647 | 9,693 | 63,745 | 17,399 |
| Operating Expenses | 44,179 | 49,696 | 58,152 | 67,090 | 85,913 |
| Operating Income | -29,656 | -38,049 | -48,459 | -3,345 | -68,514 |
| Other Income | -8,843 | -8,795 | -8,398 | -8,172 | -7,447 |
| Pre-tax Income | -38,499 | -46,844 | -56,857 | -11,517 | -75,961 |
| Income Tax | -15 | -82 | N/A | -18 | 7 |
| Net Income Continuous | -38,484 | -46,762 | -56,857 | -11,499 | -75,968 |
| Net Income | $-38,484 | $-46,762 | $-56,857 | $-11,499 | $-75,968 |
| EPS Basic Total Ops | -2.94 | -5.31 | -6.70 | -1.40 | -9.08 |
| EPS Basic Continuous Ops | -2.94 | -5.35 | -6.70 | -1.36 | -9.08 |
| EPS Diluted Total Ops | -2.94 | -5.31 | -6.70 | -1.40 | -9.08 |
| EPS Diluted Continuous Ops | -2.94 | -5.35 | -6.70 | -1.36 | -9.08 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -6.70 | -1.40 | -9.10 |
| EBITDA(a) | $-28,823 | $-36,956 | $-47,314 | $-2,478 | $-67,730 |